Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
life sciences
national blog main
9
×
national top stories
raleigh-durham blog main
9
×
san francisco blog main
9
×
biotech
detroit blog main
new york blog main
raleigh-durham top stories
san diego blog main
san francisco top stories
seattle blog main
texas blog main
wisconsin blog main
boulder/denver blog main
cancer
detroit top stories
indiana blog main
national
new york top stories
san diego top stories
seattle top stories
texas top stories
wisconsin top stories
boulder/denver top stories
indiana top stories
clinical trials
fda
ipo
medical devices
merck
pfizer
startups
boehringer ingelheim
cancer immunotherapy
celgene
crispr
deals
What
life
9
×
science
bio
companies
ipo
roundup
week
biotechs
firms
capital
company
little
millions
moves
new
public
sciences
therapeutics
admits
ago
arena’s
bails
becker
better
big
billions
black
blood
boston’s
bounty
brand
bridgebio
broader
cancer
car
chose
cig
city
classes
close
Language
unset
Current search:
life
×
" national blog main "
×
" raleigh-durham blog main "
×
" san francisco blog main "
×
@xconomy.com
3 years ago
Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
Five Years After Y Combinator First Admits Biotechs, They’re Dug In
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More
@xconomy.com
5 years ago
Six Life Science Firms Close Q3 with an IPO, More Are on the Way
@xconomy.com
5 years ago
In Boston’s Shadow, Rhode Island Fights for Life Science Jobs, Respect
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M